ARCHIVES

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

This article is from The Cancer Letter archive.

Vol. 40 No. 17 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report

May 19, 2000

Cancer Mortality By County For 1950-69 Now Available From GPO; Price-$9

April 26, 1974

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015

February 14, 2003